Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Ranke

Showing results (231-240 of 249) with videos related to

Pageof 25
Sort By:
Cardiovascular Research|March 23, 2000
Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathyK J Osterziel, S M Bode-Böger, O Strohm, et al.
Archives of Disease in Childhood|September 1, 1996
Spontaneous growth in idiopathic short stature. European Study GroupL T Rekers-Mombarg, J M Wit, G G Massa, et al.
Lancet (London, England)|June 27, 1998
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathyK J Osterziel, O Strohm, J Schuler, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)M O Savage, W F Blum, M B Ranke, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized malesM W Elmlinger, I Mayer, D Schnabel, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Phenotype: genotype relationships in growth hormone insensitivity syndromeK A Woods, F Dastot, M A Preece, et al.
Journal of the American College of Cardiology|August 14, 2001
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormoneS D Anker, M Volterrani, C D Pflaum, et al.
Clinical Endocrinology|August 31, 2002
Malnutrition, zinc supplementation and catch-up growth: changes in insulin-like growth factor I, its binding proteins, bone formation and collagen turnoverC P Doherty, P M Crofton, M A K Sarkar, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 19, 2011
Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS dataT Reinehr, S Bechtold-Dalla Pozza, M Bettendorf, et al.
European Journal of Endocrinology|November 26, 2002
Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001M B Ranke, C J Partsch, A Lindberg, et al.
Pageof 25

Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
Cardiovascular Research|March 23, 2000
Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathyK J Osterziel, S M Bode-Böger, O Strohm, et al.
Archives of Disease in Childhood|September 1, 1996
Spontaneous growth in idiopathic short stature. European Study GroupL T Rekers-Mombarg, J M Wit, G G Massa, et al.
Lancet (London, England)|June 27, 1998
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathyK J Osterziel, O Strohm, J Schuler, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)M O Savage, W F Blum, M B Ranke, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized malesM W Elmlinger, I Mayer, D Schnabel, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Phenotype: genotype relationships in growth hormone insensitivity syndromeK A Woods, F Dastot, M A Preece, et al.
Journal of the American College of Cardiology|August 14, 2001
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormoneS D Anker, M Volterrani, C D Pflaum, et al.
Clinical Endocrinology|August 31, 2002
Malnutrition, zinc supplementation and catch-up growth: changes in insulin-like growth factor I, its binding proteins, bone formation and collagen turnoverC P Doherty, P M Crofton, M A K Sarkar, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 19, 2011
Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS dataT Reinehr, S Bechtold-Dalla Pozza, M Bettendorf, et al.
European Journal of Endocrinology|November 26, 2002
Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001M B Ranke, C J Partsch, A Lindberg, et al.
Pageof 25